Navigation Links
Verizon Wireless' Network Supports VectraCor's Ambulatory Cardiac Monitor
Date:1/10/2012

LAS VEGAS, BASKING RIDGE, N.J., and TOTOWA, N.J., Jan. 10, 2012 /PRNewswire/ -- From the 2012 International Consumer Electronics Show (CES), Verizon Wireless and VectraCor, Inc. today said the Vectraplex Holter System is being shown at the Verizon booth (Las Vegas Convention Center, South Hall, Booth #30259). 

The Vectraplex Holter System is an ambulatory cardiac monitor that incorporates an electrocardiogram (ECG) amplifier and a cell module using Verizon Wireless service.  Currently under development, the Vectraplex Holter will use the "Cardiac Electrical Biomarker," VectraplexAMI, which received FDA approval in November 2011, on VectraCor's VectraplexECG System.  This technology will detect ECG changes indicative of an acute myocardial infarction (AMI, heart attack), non-invasively and in real time, and display a derived 15 lead ECG from the acquisition of 3 leads (5 electrodes).  For the first time, a patient can be anywhere on the Verizon Wireless network and the Vectraplex Holter System will automatically send an email over the network to the physician when the patient is having ECG changes indicative of an AMI or other events, allowing the physician to review the derived 15 lead ECG.  The device will also send data on patient-initiated events.

Cardiovascular disease is the No. 1 killer in the world, and the need to improve the detection and monitoring of a heart attack is crucial.  The current emergency room practice of chest pain evaluation is to connect the patient to a cardiac monitor (3-5 electrodes), then connect an additional 12 lead ECG machine (additional 10 electrodes), and then draw blood to measure serum biomarkers, repeated approximately every three to six hours during an 18- to 24-hour-period.

The Vectraplex Holter System is an ambulatory cardiac monitor that patients can wear at home or in the hospital to detect ECG changes suggestive of an AMI within seconds and derive the 15 lead ECG (12 lead and vectorcardiogram XYZ leads, including VCG loops) from the acquisition of only 3 leads (5 electrodes).  VectraCor's disruptive technology is patented worldwide and will provide valuable clinical information to both patients and clinicians.

Brad S. Schreck, president and chief executive officer for VectraCor, said, "VectraCor is very pleased to work with Verizon Wireless, enabling our disruptive technology to help patients with cardiovascular disease, the No. 1 killer in the world.  We expect to submit the 510k to the FDA in the first quarter of 2012 for this new product."

Verizon established its Innovation Program to encourage collaboration and help advance the 4G LTE ecosystem.  The company's LTE Innovation Center in Waltham, Mass., and its Application Innovation Center in San Francisco were created to inspire, enable and develop non-traditional devices, services and applications that take advantage of Verizon Wireless' industry-leading wireless networks.  Through the Innovation Program, Verizon seeks to expand the possibilities of 4G LTE by working with diverse companies, from start-ups to established players, in industries representing a broad range of verticals.

For more information about Verizon at CES, visit www.verizonwireless.com/ces or follow Verizon Wireless news on Twitter at @VZWnews.  Visit www.vectracor.com for more information about VectraCor.

About Verizon Wireless
Verizon Wireless operates the nation's largest 4G LTE network and largest, most reliable 3G network. The company serves 107.7 million total wireless connections, including 90.7 million retail customers.  Headquartered in Basking Ridge, N.J., with nearly 83,000 employees nationwide, Verizon Wireless is a joint venture of Verizon Communications (NYSE, NASDAQ: VZ) and Vodafone (LSE, NASDAQ: VOD).  For more information, visit www.verizonwireless.com. To preview and request broadcast-quality video footage and high-resolution stills of Verizon Wireless operations, log on to the Verizon Wireless Multimedia Library at www.verizonwireless.com/multimedia.    

About VectraCor, Inc.
VectraCor is a medical device company in Totowa, NJ with disruptive patented technology in the cardiovascular market place.  Cardiovascular disease is the #1 disease and killer in the US and World.  VectraCor's technology has the potential to be the new standard of care in cardiac monitoring. For more information please visit VectraCor at www.vectracor.com or contact Brad S. Schreck at 973-768-0402 or email bschreck@vectracor.com.  


'/>"/>
SOURCE Verizon Wireless
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Verizon Wireless and Medco Unveil First Mobile Medication App with Real-Time Patient-Specific Drug Safety and Savings Information
2. BL Healthcares Next Generation of Wireless Remote Healthcare Solutions, Now on Verizon Wireless 4G LTE Mobile Broadband Network
3. Verizon Expands Medical Data Exchange to Include Broader Range of Patient Health Data
4. Specialized Verizon Business Security Consulting Services Help Identify, Protect Personal Health Data
5. Verizon Business Adds Riverbed Application Acceleration Technology, New Consulting Services to Boost Performance of Key Business Applications
6. Verizon Wireless Offers Home Health Care Industry Custom Mobile Application To Be More Productive
7. Wireless Engineering Pioneer Joins NYU-Poly and NYU
8. Sotera Wireless Completes $12.2 Million Series D Financing, Signs Agreement with Cerner
9. Hello Health Inc. to Wirelessly Integrate the Hello Health® Patient Management Platform onto Qualcomm Lifes 2net Platform
10. BodyMedia Plans to Join Qualcomm Lifes Wireless Health 2net Ecosystem
11. CareFusion Launches Wireless Diagnostic and Monitoring Neurological Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... April 27, 2016 Tie-up with ... initiative to save newborns   Fortis ... & newborns in collaboration with Breast Milk Foundation (BMF), a ... Pasteurized Human Milk Bank, ,Amaara, in Delhi-NCR today. This non-profit ... source for infants and should be available to babies deprived ...
(Date:4/27/2016)... YORK , April 27, 2016 ... OASM ), a developer of a new generation ... announced positive overall survival results for Paclical/Apealea in ... of 789 patients with epithelial ovarian cancer. These ... groups: Paclical/Apealea in combination with carboplatin versus Taxol ...
(Date:4/26/2016)... Diplomat Pharmacy, Inc. (NYSE: DPLO) is pleased ... Pharm D., to Vice President of Education and Quality. ... will continue to lead and oversee Diplomat University, an ... and training to Diplomat employees and external professionals on ... also houses the quality assurance department, which focuses on ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 29, 2016 , ... In an article ... shares her enthusiasm for Botox and lip injections, which she underwent in order to ... Coachella Valley Music and Arts Festival. The article explains that Ms. Mirmelli’s situation is ...
(Date:4/29/2016)... ... , ... Our bodies are bombarded daily by environmental and lifestyle factors that ... is to adopt a more healthful diet, but too many people think that food ... Nutritionist and the creator of the Newport Beach Cleanse and 14-Day Eating Plan, disagrees ...
(Date:4/29/2016)... ... April 29, 2016 , ... The White House announced ... loans, more information about their loan terms and accounts, and more protections for ... including federal and private loans, has reached $1.3 trillion, with 43 million Americans ...
(Date:4/29/2016)... ... ... Spine Team Texas, a comprehensive spine physician group specializing in the treatment ... been invited to be a featured speaker at the Texas Society of the American ... 2016. , Dr. R. Scott McPherson, a physical medicine and rehabilitation specialist, will ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... Canadian Celiac Association (CCA), is pleased to announce the launch of the ... nutritional articles, recipes, and more. The purpose of the GFCP Scoop ...
Breaking Medicine News(10 mins):